Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

JRSIS Health Care Corporation (JRSS)

Compare
0.0323
+0.0323
(0.00%)
At close: April 11 at 4:00:00 PM EDT
Loading Chart for JRSS
  • Previous Close 0.0323
  • Open 0.0323
  • Bid 0.0224 x 40000
  • Ask 0.0323 x 40000
  • Day's Range 0.0323 - 0.0323
  • 52 Week Range 0.0228 - 2.2000
  • Volume 11,800
  • Avg. Volume 165,441
  • Market Cap (intraday) 2.733M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.

www.jhcc.cn

36

Full Time Employees

December 31

Fiscal Year Ends

Recent News: JRSS

View More

Performance Overview: JRSS

Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

JRSS
78.47%
S&P 500 (^GSPC)
8.09%

1-Year Return

JRSS
96.37%
S&P 500 (^GSPC)
5.52%

3-Year Return

JRSS
98.53%
S&P 500 (^GSPC)
23.07%

5-Year Return

JRSS
99.84%
S&P 500 (^GSPC)
89.95%

Compare To: JRSS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: JRSS

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    2.73M

  • Enterprise Value

    4.13M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.08

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.19

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.12%

  • Return on Assets (ttm)

    -32.02%

  • Return on Equity (ttm)

    -478.87%

  • Revenue (ttm)

    3.47M

  • Net Income Avi to Common (ttm)

    -489.98k

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.37k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -498.45k

Research Analysis: JRSS

View More

Company Insights: JRSS

Research Reports: JRSS

View More

People Also Watch